Pericarditis Pipeline: Emerging Therapies and Key pharma players involved by DelveInsight | Kiniska Pharmaceuticals, R-Pharm International, LLC and Others.

Pericarditis Pipeline: Emerging Therapies and Key pharma players involved by DelveInsight | Kiniska Pharmaceuticals, R-Pharm International, LLC and Others.

Pericarditis Pipeline

Pericarditis is characterized by swelling and irritation in the pericardial sac, and often a pericardial effusion. The condition causes sharp chest pain when the irritated pericardium layer rub against each other. It can be grouped into different categories which include acute pericarditis, recurrent pericarditis, incessant, and chronic constrictive pericarditis. Pericarditis occurs in people of all ages, although viral pericarditis is more common in adults than in children. In contrast, purulent pericarditis is common in children. Although, pericarditis is usually mild and does not require treatment however, more severe cases may include medications such as colchicine, pain relievers, corticosteroids and surgeries in very rare cases.

DelveInsight’s, Pericarditis Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Pericarditis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. 


Get a free Sample Copy:


Some of Pericarditis Companies:

  • Kiniska Pharmaceuticals
  • R-Pharm International, LLC 
  • And Many Others


DelveInsight’s Pericarditis report covers around 3+ products under different phases of clinical development like:

  • Late stage products (Phase III)
  • Mid-stage products (Phase II)
  • Early-stage product (Phase I) along with the details of
  • Pre-clinical and Discovery stage candidates
  • Discontinued & Inactive candidates
  • Route of Administration


Get a free Sample Copy:


Some of Pericarditis Therapies are:

  • Rilonacept
  • RPH-104
  • And Many Others


Current Pericarditis Treatment Scenario and Pericarditis Emerging Therapies:

  • How many companies are developing Pericarditis drugs?
  • How many Pericarditis drugs are developed by each company?
  • How many emerging drugs are in mid-stage, and late-stage of development for the treatment of Pericarditis?
  • What are the key collaborations (Industry–Industry, Industry–Academia), Mergers and acquisitions, licensing activities related to the Pericarditis therapeutics?
  • What are the recent trends, drug types and novel technologies developed to overcome the limitation of existing therapies?
  • What are the clinical studies going on for Pericarditis and their status?
  • What are the key designations that have been granted to the emerging drugs?


Get a free Sample Copy:


Table of Contents:


Executive Summary

Pericarditis: Overview

Pipeline Therapeutics

  • Comparative Analysis

Therapeutic Assessment

Pericarditis – DelveInsight’s Analytical Perspective

In-depth Commercial Assessment

  • Pericarditis companies’ collaborations, Licensing, Acquisition -Deal Value Trends

Pericarditis Collaboration Deals

Late Stage Products (Pre-registration)

  • Comparative Analysis

Rilonacept: Kiniska Pharmaceuticals

Late Stage Products (Phase II/III)

  • Comparative Analysis

RPH-104: R-Pharm International, LLC

Drug profiles in the detailed report…..

Inactive Products

  • Comparative Analysis

Pericarditis Key Companies

Pericarditis Key Products

Pericarditis- Unmet Needs

Pericarditis- Market Drivers and Barriers

Pericarditis- Future Perspectives and Conclusion

Pericarditis Analyst Views

Pericarditis Key Companies


Request for Deatiled TOC:


About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States